<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
<channel>
<title>PRWeb.com Press Release Feed - PRWeb Press Release Account Feed</title>
<link>http://www.rsspad.com/rss2a/203519.xml</link>
<description>PRWeb.com Press Release Feed - Press Releases</description>
<language>en</language>
<managingEditor>xml@emediawire.com</managingEditor>
<webMaster>xml@emediawire.com</webMaster>
<ttl>30</ttl>
<item>
     <title>Stock Strategy Reporting Resource Tool</title>
     <link>http://www.prweb.com/releases/2006/09/prweb434670.htm</link><description>   <![CDATA[ <P>Many stock futures strategies reduced to three fundamentally weighted outlook stock price categories. (PRWeb Sep 15, 2006)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2006/09/prweb434670.htm">http://www.prweb.com/releases/2006/09/prweb434670.htm</a></P>]]>
                </description><pubDate>Fri, 15 Sep 2006 07:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2006/09/prweb434670.htm</guid>
        </item>
<item>
     <title>NeoVid Pharmaceuticals Announces Investigation of New Cancer Drug</title>
     <link>http://www.prweb.com/releases/2006/06/prweb397695.htm</link><description>   <![CDATA[ <P>A new cancer drug compound (dTCTinicyclic acid HCL), given the brand name Azatrol, is being investigated for a cure to cancer. (PRWeb Jun 14, 2006)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2006/06/prweb397695.htm">http://www.prweb.com/releases/2006/06/prweb397695.htm</a></P>]]>
                </description><pubDate>Wed, 14 Jun 2006 07:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2006/06/prweb397695.htm</guid>
        </item>
</channel>
</rss>